NOVARTIS N 2. LINIE revenue breakdown overview

NOVARTIS N 2. LINIE revenue for the last year amounted to 45.70 B CHF, the most of which — 12.98 B CHF — came from its highest performing source at the moment, Oncology, the year earlier bringing 12.21 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought NOVARTIS N 2. LINIE 18.62 B CHF, and the year before that — 16.14 B CHF.